Biolatam Attracts Biotechnology Risk Capital Funds Managing a Total of Over 3 Billion Euros

  • Proexport Colombia Will Support the Presence of International Investment Funds
  • 14 Firms Have so Far Confirmed Their Attendance, the Organisation Expects to Bring Together 25 Companies in Bogotá

MADRID, Nov. 14, 2013 (GLOBE NEWSWIRE) -- The first edition of Biolatam, the biggest event for global biotechnology with a focus on Latin America, which will take place in Bogota (Colombia) on the 9th and 10th of December of this year, will be a key meeting point for investors and entrepreneurs from across the life sciences.

For this event, Proexport Colombia, the Colombian government agency responsible for the promotion of direct foreign investment into the country, has facilitated the attendance of international investment funds managing a total of over 3 billion euros in portfolios centred around health and technology. So far 14 investment funds have confirmed their attendance but the final number is expected to rise to 25.

The investment funds whose attendance has been confirmed are Austral Capital (Chile), Burrill Brasil Gestão de Recursos (Brazil), CRB INVERBIO S.A. SGECR (Spain), Inveready Biotech II SCR (Spain), Ventac Partners (US), Ysios Capital Partners SGECR (Spain), ZFunction (US), Wellington Partners (UK), Forbion Capital Partners (Netherlands), Flagship Ventures (US), Edrip (Edmond de Rothschild Investment Partners), from France, Inversiones de Vanguardia (Colombia), Velum Partners (Colombia) and the Red Nacional de Ángeles Inversionistas (Colombia) led by Fundación Bavaria.

Amongst the most important are Wellington, based in London, which manages four funds comprising over 800 million euros invested in 30 companies working in areas such as medical technology, diagnosis, therapy and industrial biotechnology; Flagship, from Boston, which manages 900 million euros for seed and early-stage investments, with some later stage value investments. Its portfolio is made up of 28 companies. Forbion, based in Amsterdam, manages four funds accounting for over 450 million euros, has invested in companies working on late stage preclinical / early stage clinical development programs. It has 27 companies in its portfolio.

The Biolatam conference programme will include a especial Seminar, on the 9th of December, which will be made up of three sessions focused on financing. The first will be, Public Policy to support risk capital in biotechnology, the second, What are investors searching for in Latin American Biotechnology and the third seminar will be on Risk Capital specialised in Biotechnology; what international investors experience. During the seminar, which will be presided by the former Spanish minister for Science and Innovation, Cristina Garmendia, successful case studies of PPP funds will be studied and cross-shareholdings between Europe, the US and Latin America will be debated. The challenge of how to attract big fortunes and business angels to the sector will also be covered.

During the first session speakers will include Consuelo Valverde, founder of ZFunction (US); Felipe Camposano, General Partner de Austral Capital and Presidente of the Chilean Association for Biotechnology (Chile) (ASEMBIO) and representatives of iNNpulsa (Colombia) and the CDTI (Spain). During the second session, which will be moderated by Ángel Santos, Director of Business Development at CRB Inverbío SGECR (Spain), the speakers will include João Paulo Poiares Baptista, Director General of Burrill Brasil Gestão de Recursos S.A. (Brazil) and Santiago de Torres, President of Inveready Biotech II SCR (Spain). The last session will be moderated by Joël Jean-Mairet, Managing Partner of Ysios Capital Partners (Spain) and the confirmed speakers are Gilles Nobercourt, Partner of Edmond de Rothschild (France); Sander Slootweg, Managing Partner of Forbion Capital Partners (Netherlands); Ignacio Martinez, Partner of Flagship Ventures (US-MA) and Arun R. Jayadev, Principal of Wellington Partners (UK).


BIOLATAM is a global partnering forum with a Latin American focus, it is open to companies, researchers and risk capital entities. The partnering section will be managed using PartneringOne software provided by EBD Group – which has been a service provider for Biospain and other high profile fairs- and will include a conference programme on bioeconomy, biocomfuels, advanced therapies, food biotechnology, personalised medicine, health products and risk capital as well as other subject areas.

For this first edition of BIOLATAM, we expect to exceed 500 attendees, with a high participation of US delegates, Latin American and European countries, as well as the presence of relevant biotechnology markets, such as that of Japan, Israel and Canada.

The event aspires to take place on a biennial basis on odd numbered years with the objective of becoming the leading forum in Latin America for the biotechnology sector and the promotion and development of business relationships between biotechnology companies as well as their relationship with user and associated sectors (pharma, health products, food, veterinary products, energy, among others) from all over the world but with particular interests in Latin American countries.


The Spanish Bioindustry Association (ASEBIO) comprises 255 members, mainly small businesses born out of the research activities of universities and national research centres.

ASEBIO has, since 1999, been a meeting point and platform for the promotion of those organisations interested in the national biotechnology field. To that end, ASEBIO works closely with regional, national and European administrations, as well as all those social organisations interested in the use of biotechnology for the improvement of our quality of life, the environment and the creation of highly skilled jobs.

About Invest in Bogota

Invest in Bogota is the investment promotion agency for the Bogota region, a public-private partnership between the Bogota Chamber of Commerce and Bogota City Council. Its mission is to support investors who are exploring opportunities in Bogota. In 2009 The World Bank ranked it as the best non-OECD investment promotion agency in the world. It offers specialised services to investors, on a free of charge and fully confidential basis, at every stage of the investment process: the exploratory phase, the decision making stage, the start-up process, the operational phase and in reinvestment.

About Proexport

Proexport is the entity that promotes international tourism, foreign investment and non-traditional exports in Colombia. Through its national and international network of offices, it offers support and integral consultancy to clients through services or instruments aimed at facilitating design and execution of its globalization strategy, which seeks to generate, develop and close business opportunities.

Press release (PDF):

CONTACT: For further information please contact: Lucia Cecilia Head of Communications at BIOLATAM and ASEBIO Telephone. + 34 91 2109374/10 Fax. +34 91 2500063 Mobile: +34 663 117 293 e-mail: Adriana Rodriguez C. Marketing and Communications Officer at Invest in Bogota Telephone. +57 1 1 7423030 e-mail: arodriguez@investinbogota.orgSource:Asociacion Espanolade Bioempresas